Safety and efficacy of BAY1436032 in IDH1-mutant AML: phase I study results
BAY1436032治疗IDH1突变型急性髓系白血病的安全性和有效性：I期研究结果
期刊:Leukemia
影响因子:13.4
doi:10.1038/s41375-020-0996-5
Heuser, Michael; Palmisiano, Neil; Mantzaris, Ioannis; Mims, Alice; DiNardo, Courtney; Silverman, Lewis R; Wang, Eunice S; Fiedler, Walter; Baldus, Claudia; Schwind, Sebastian; Pardee, Timothy; Perl, Alexander E; Cai, Charles; Kaulfuss, Stefan; Lagkadinou, Eleni; Rentzsch, Christine; Wagner, Markus; Wilkinson, Gary; Wu, Bingyan; Jeffers, Michael; Genvresse, Isabelle; Krämer, Alwin
